StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.85−0.06 (-1.22%)

Close on Nov 18, 2026Market cap $59.59MP/E –Yield –

Lensar cash

Cash and short-term investments held at the end of each period.

Lensar's cash was $13.57M at Jun 30, 2026. For fiscal 2025 it was $17.98M, down 19.9% from the year before. The highest annual figure on record is $40.60M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$17.98M-19.9%
FY2024Dec 31, 2024$22.46M-6.7%
FY2023Dec 31, 2023$24.06M+64.0%
FY2022Dec 31, 2022$14.67M-53.6%
FY2021Dec 31, 2021$31.64M-22.1%
FY2020Dec 31, 2020$40.60M+779.7%
FY2019Dec 31, 2019$4.62M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$13.57M-33.2%
Q1 FY2026Mar 31, 2026$13.50M-46.5%
Q4 FY2025Dec 31, 2025$17.98M-19.9%
Q3 FY2025Sep 30, 2025$16.87M-6.7%
Q2 FY2025Jun 30, 2025$20.31M+42.9%
Q1 FY2025Mar 31, 2025$25.25M+41.0%
Q4 FY2024Dec 31, 2024$22.46M-6.7%
Q3 FY2024Sep 30, 2024$18.08M-27.4%
Q2 FY2024Jun 30, 2024$14.21M-44.2%
Q1 FY2024Mar 31, 2024$17.91M+124.7%
Q4 FY2023Dec 31, 2023$24.06M+64.0%
Q3 FY2023Sep 30, 2023$24.92M+29.2%
Q2 FY2023Jun 30, 2023$25.47M+1.1%
Q1 FY2023Mar 31, 2023$7.97M-72.5%
Q4 FY2022Dec 31, 2022$14.67M-53.6%
Q3 FY2022Sep 30, 2022$19.29M-40.3%
Q2 FY2022Jun 30, 2022$25.20M-27.1%
Q1 FY2022Mar 31, 2022$28.98M-19.2%
Q4 FY2021Dec 31, 2021$31.64M-22.1%
Q3 FY2021Sep 30, 2021$32.34M-24.3%
Q2 FY2021Jun 30, 2021$34.55M+648.7%
Q1 FY2021Mar 31, 2021$35.87M–
Q4 FY2020Dec 31, 2020$40.60M–
Q3 FY2020Sep 30, 2020$42.70M–
Q4 FY2019Dec 31, 2019$4.62M–

More Lensar figures

See a number that looks wrong?